Autolus Therapeutics Selects Cardinal Health as U.S. Commercial Distribution Partner
27 avr. 2023 07h00 HE
|
Autolus Therapeutics plc
Cardinal Health to provide core distribution capabilities required for U.S. commercialization of CAR T-cell therapiesInnovative Depot Model intended to reduce delivery time by allowing for transit...